Atossa Therapeutics Statistics
Total Valuation
ATOS has a market cap or net worth of $41.51 million. The enterprise value is $207,760.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, before market open.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATOS has 8.61 million shares outstanding. The number of shares has increased by 2.63% in one year.
| Current Share Class | 8.61M |
| Shares Outstanding | 8.61M |
| Shares Change (YoY) | +2.63% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 20.35% |
| Float | 8.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.53
| Current Ratio | 5.53 |
| Quick Ratio | 5.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -62.74% and return on invested capital (ROIC) is -41.89%.
| Return on Equity (ROE) | -62.74% |
| Return on Assets (ROA) | -37.42% |
| Return on Invested Capital (ROIC) | -41.89% |
| Return on Capital Employed (ROCE) | -94.38% |
| Weighted Average Cost of Capital (WACC) | 11.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.32M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.39% in the last 52 weeks. The beta is 1.34, so ATOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -50.39% |
| 50-Day Moving Average | 5.19 |
| 200-Day Moving Average | 10.44 |
| Relative Strength Index (RSI) | 44.33 |
| Average Volume (20 Days) | 75,612 |
Short Selling Information
The latest short interest is 320,202, so 3.72% of the outstanding shares have been sold short.
| Short Interest | 320,202 |
| Short Previous Month | 361,039 |
| Short % of Shares Out | 3.72% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 3.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.14M |
| Pretax Income | -34.77M |
| Net Income | -34.77M |
| EBITDA | -37.13M |
| EBIT | -37.14M |
| Earnings Per Share (EPS) | -$4.04 |
Full Income Statement Balance Sheet
The company has $41.30 million in cash and n/a in debt, with a net cash position of $41.30 million or $4.80 per share.
| Cash & Cash Equivalents | 41.30M |
| Total Debt | n/a |
| Net Cash | 41.30M |
| Net Cash Per Share | $4.80 |
| Equity (Book Value) | 39.35M |
| Book Value Per Share | 4.57 |
| Working Capital | 37.36M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$29.76 million and capital expenditures -$23,000, giving a free cash flow of -$29.79 million.
| Operating Cash Flow | -29.76M |
| Capital Expenditures | -23,000 |
| Depreciation & Amortization | 16,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -29.79M |
| FCF Per Share | -$3.46 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.63% |
| Shareholder Yield | -2.63% |
| Earnings Yield | -83.77% |
| FCF Yield | -71.76% |
Analyst Forecast
The average price target for ATOS is $28.33, which is 487.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.33 |
| Price Target Difference | 487.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 2, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Feb 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |